<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Big-Health on 生物经济</title><link>https://cn.bioecon.ru/companies/big-health/</link><description>Recent content in Big-Health on 生物经济</description><generator>Hugo</generator><language>zh-CN</language><lastBuildDate>Mon, 20 Jul 2026 22:09:50 +0700</lastBuildDate><atom:link href="https://cn.bioecon.ru/companies/big-health/index.xml" rel="self" type="application/rss+xml"/><item><title>数字疗法</title><link>https://cn.bioecon.ru/technology/digital-therapeutics/</link><pubDate>Mon, 20 Jul 2026 00:00:00 +0000</pubDate><guid>https://cn.bioecon.ru/technology/digital-therapeutics/</guid><description>提供经监管机构批准临床干预（而非一般健康支持）的软件医疗器械——用于ADHD、失眠、焦虑与抑郁的处方数字疗法、肌肉骨骼数字康复及儿童孤独症数字干预：美国的Akili Interactive、Big Health与Click Therapeutics，德国的Kaia Health，以及中国的ALSOLIFE。</description></item></channel></rss>